Jason Haas, Director at LIGAND PHARMACEUTICALS INC (LGND), sold 6,461 shares at $255.01 ($1.7M) on 2026-06-12, disclosed to the SEC on 2026-06-15.
Seasonal sale ($1.7M) by Director — this insider has traded LGND in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $255.01 | 3,000 | $765K | 46.3% |
| 2 | $256.08 | 3,461 | $886K | 53.7% |
| Total | $255.58 avg | 6,461 | $1.7M | 100% |
| Filing → |
| SYRS | SELL | 2024-11-20 | $29K | — | Filing → |
| SYRS | BUY | 2024-09-12 | $292K | — | Filing → |